# US 2024/0189482 A1 · Human nasal turbinate-derived mesenchymal stem cell-based, 3d bioprinted construct, and use thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0189482 A1
- Document ID: US20240189482A1
- Status: Published application
- Kind: A1
- Application number: 18/583,237
- Filed: 2024-02-21
- Published: 2024-06-13
- Earliest claimed: 2017-05-02
- Assignees: Catholic University Industry Academic Cooperation Foundation
- Applicants: Catholic University Industry Academic Cooperation Foundation
- Inventors: Sung Won KIM; Jung Yeon LIM; Sun Hwa PARK; Byeong Gon YOON; Dong-Woo CHO; Jinah JANG; Seok Won KIM
- Web page: https://patentgrep.com/patent/US20240189482A1

## CPC

- A61L 27/3834: {Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells}
- C12N 5/0668: {Mesenchymal stem cells from other natural sources}
- A61L 27/20: Polysaccharides
- A61L 27/24: Collagen
- A61L 27/52: Hydrogels or hydrocolloids
- A61L 27/54: Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)}
- C12N 5/0697: {Artificial constructs associating cells of different lineages, e.g. tissue equivalents (blood vessels C12N5/0691)}
- A61L 2400/06: Flowable or injectable implant compositions
- A61L 2430/06: for cartilage reconstruction, e.g. meniscus
- C12N 2513/00: 3D culture
- C12N 2533/54: Collagen; Gelatin
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

Provided are a method for fabricating a human nasal turbinate-derived mesenchymal stem cell-based 3D bioprinted construct, and a use thereof, wherein the human nasal turbinate-derived mesenchymal stem cell-based, 3D bioprinted construct is advantageous over conventional mesenchymal stem cell-based, 3D bioprinted constructs in that the former can survive and proliferate stably in vitro and/or in vivo and shows high osteogenic differentiation ability as well, therefore is expected to make a great contribution to the practical use of cellular therapeutic agents.

## Claims

### Claim at position 1

-5. (canceled)

### Claim 6

A method for treating a bone defect comprising administering to a subject in need thereof, a cellular therapeutic agent comprising a human nasal turbinate-derived mesenchymal stem cell-based 3D bioprinted stem cell construct as an active ingredient.

### Claim 7 (depends on 6)

The method of claim 6, wherein the human nasal turbinate-derived mesenchymal stem cell-based 3D bioprinted stem cell construct is fabricated by a method comprising:
(a) isolating mesenchymal stem cells from a nasal turbinate tissue collected during the process of surgically removing the human nasal turbinate;
(b) fabricating a bio-ink by encapsulating the isolated mesenchymal stem cells in a hydrogel; and
(c) fabricating a 3D bioprinted stem cell construct by a micro-extrusion method comprising mixing the bio-ink with polycaprolactone (PCL).

### Claim 8 (depends on 7)

The method of claim 7, further comprising stabilizing the 3D bioprinted stem cell construct fabricated in step (c) in a stabilization culture broth.

### Claim 9 (depends on 7)

The method of claim 7, wherein the hydrogel in step (b) is collagen or alginate.
